Sewer sampling, the authors say, could be expanded to track other infectious diseases such as H5N1 avian flu or mpox or to detect unexpected pathogens.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Also, new CDC data show why immune-compromised people need an added COVID vaccine dose.
Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
"As we await CDC's decision, we are not waiting on operations or logistics."
The group agreed on a goal of vaccinating at least 70% of the world's population by the middle of next year.
A third Pfizer COVID-19 vaccine dose is 92% more effective in reducing severe COVID-related outcomes than two doses of the same vaccine received at least 5 months previously, according to a large real-world study late last week in The Lancet.
The acting FDA chief says the move will bring us closer to a sense of normalcy.
The secondary attack rate was 25% in fully vaccinated people and 38% in the unvaccinated.
The authors say all eligible people should get the vaccine ASAP, including those previously infected.
Cancer patients who received systemic treatment like chemotherapy or radiation in the 3 months before testing positive for COVID-19 were at increased risk of death, admission to an intensive care unit (ICU), and hospitalization, according to a study yesterday in JAMA Oncology.
The cheap drug fluvoxamine reduced the need for a long emergency department visit or a hospital stay.